Taylor Morrison Home Corporation
NYSE:TMHCResidential Construction
+$0.33 today
- Market cap
- $6.67B
- Beta
- 1.48
- P/E (TTM)
- 10.3
- EPS (TTM)
- $7.00
Volume 2.52M
Average 2.42M
TMHC Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Taylor Morrison Home CorporationNYSE: TMHC
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures grows in line with its trailing trend
Q1 FY2026 capital expenditures of $9.96M (cash outflow) rose 17.0% year over year, in line with the +17.0% change in trailing-twelve-month capital expenditures. Sequentially, it fell 10.5% from the prior quarter. Over 3 fiscal years it compounded at +9.7% a year.
Context
- Capital expenditures amounted to 0.5% of revenue in FY2025, unchanged from a year earlier.
- Capital expenditures grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +17.0% toward the trailing-twelve-month pace of +17.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (40.37M) USD
- Year-over-year change
- -11.1%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (40.37M) | -11.1% |
| FY2024 | 2024-12-31 | (36.33M) | -8.7% |
| FY2023 | 2023-12-31 | (33.43M) | -9.3% |
| FY2022 | 2022-12-31 | (30.58M) | -44.3% |
| FY2021 | 2021-12-31 | (21.2M) | — |
Capital Expenditures vs competitors
How TMHC compares with its peers on the latest reported figures
- TMHC's LTM Mar 2026 capital expenditures of $41.82M is the 9th largest of the 11 companies compared; the peer median is $58.68M.
- Its year-over-year change of +17.0% is the 6th highest of 11, against a peer median of +14.8%.
- Capital expenditures amounts to 0.5% of revenue for TMHC, versus a peer median of 2.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Oct 2026 | $663M | +18.6% | -4.2% | 2.8% | |
| LTM Jul 2026 | $420.68M | +119.9% | +9.3% | 6.5% | |
| LTM Aug 2026 | $270M | -54.4% | -34.0% | 1.2% | |
| LTM Aug 2026 | $242M | +11.0% | -10.3% | 3.4% | |
| LTM Sep 2026 | $65.6M | +199.5% | +15.6% | 2.2% | |
| LTM Jun 2026 | $51.76M | +102.3% | -7.1% | 2.3% | |
| LTM Sep 2026 | $48M | -12.7% | +5.7% | 3.3% | |
| LTM Aug 2026 | $46.3M | +3.6% | +2.3% | 0.9% | |
| LTM Mar 2026 | $41.82M | +17.0% | +9.7% | 0.5% | |
| LTM Sep 2026 | $19.49M | -29.4% | -1.6% | 0.4% | |
| LTM Sep 2026 | $13.42M | +80.8% | +1.0% | 0.3% | |
| Peer median (excluding TMHC) | $58.68M | +14.8% | -0.3% | 2.2% | |
Competitors are the stored peer set for TMHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 682.37M | 1.06B | 768.93M | 886.57M | 782.5M |
| Depreciation & Amortization | 39.98M | 33.84M | 33.41M | 41.19M | 40.18M |
| Deferred Income Tax | 86.84M | 83.58M | (169K) | (8.42M) | 1.89M |
| Stock-Based Compensation | 19.94M | 26.9M | 26.1M | 22.46M | 0 |
| Change in Working Capital | (495.62M) | (180.47M) | (48.76M) | (848.11M) | (182.72M) |
| Accounts Receivables | (524.06M) | 0 | 31.01M | 0 | 0 |
| Inventory | (343.13M) | (50.79M) | (78.58M) | (797.33M) | 26.58M |
| Accounts Payables | 197.12M | (61.85M) | 84.81M | 215.99M | 0 |
| Other Working Capital | 174.45M | (67.82M) | (86.01M) | (266.78M) | (209.3M) |
| Other Non-Cash Items | 43.14M | 87.67M | 26.67M | 116.4M | 205.9M |
| Operating Cash Flow | 376.65M | 1.11B | 806.17M | 210.08M | 847.75M |
| Capital Expenditures | (21.2M) | (30.58M) | (33.43M) | (36.33M) | (40.37M) |
| Acquisitions (Net) | (74.98M) | (109.57M) | (64.59M) | (129.81M) | 0 |
| Purchases of Investments | (10M) | (109.57M) | 0 | 0 | (146.19M) |
| Sales of Investments | 0 | 109.57M | 0 | 0 | 1.39M |
| Other Investing Activities | 31.92M | 125.28M | 824K | 29.7M | 0 |
| Investing Cash Flow | (74.26M) | (14.88M) | (97.19M) | (136.44M) | (185.17M) |
| Debt Repayment | 322.49M | (796.44M) | (517.57M) | (32.5M) | 86.46M |
| Common Stock Issued | 0 | 0 | 0 | 0 | (493K) |
| Common Stock Repurchased | (281.42M) | (376.28M) | (127.96M) | (347.6M) | (381.02M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (41.22M) | (29.88M) | 17.01M | (13.47M) | (3.46M) |
| Financing Cash Flow | (155K) | (1.2B) | (628.51M) | (393.57M) | (298.51M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 302.23M | (109.71M) | 80.46M | (319.93M) | 364.07M |
| Free Cash Flow | 355.45M | 1.08B | 772.74M | 173.75M | 807.37M |
Taylor Morrison Home Corporation
NYSE:TMHC
Intrinsic Alpha fair value
Locked
Current Price
$72.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.